Cargando…
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
Vaccines against parasites have lagged centuries behind those against viral and bacterial infections, despite the devastating morbidity and widespread effects of parasitic diseases across the globe. One of the greatest hurdles to parasite vaccine development has been the lack of vaccine strategies a...
Autores principales: | Koger-Pease, Cal, Perera, Dilhan J., Ndao, Momar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058461/ https://www.ncbi.nlm.nih.gov/pubmed/36986434 http://dx.doi.org/10.3390/ph16030334 |
Ejemplares similares
-
Promising Technologies in the Field of Helminth Vaccines
por: Perera, Dilhan J., et al.
Publicado: (2021) -
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
por: Perera, Dilhan J., et al.
Publicado: (2022) -
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
por: Perera, Dilhan J., et al.
Publicado: (2023) -
Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model
por: Hassan, Adam S., et al.
Publicado: (2019) -
Correction: Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model
por: Hassan, Adam S., et al.
Publicado: (2021)